Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care.

Details

Serval ID
serval:BIB_460A7D9C56D8
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care.
Journal
Clinical immunology
Author(s)
Oommen P.T., Strauss T., Baltruschat K., Foeldvari I., Deuter C., Ganser G., Haas J.P., Hinze C., Holzinger D., Hospach A., Huppertz H.I., Illhardt A., Jung M., Kallinich T., Klein A., Minden K., Mönkemöller K., Mrusek S., Neudorf U., Dückers G., Niehues T., Schneider M., Schoof P., Thon A., Wachowsky M., Wagner N., Bloedt S., Hofer M., Tenbrock K., Schuetz C.
ISSN
1521-7035 (Electronic)
ISSN-L
1521-6616
Publication state
Published
Issued date
12/2022
Peer-reviewed
Oui
Volume
245
Pages
109143
Language
english
Notes
Publication types: Journal Article ; Systematic Review
Publication Status: ppublish
Abstract
New therapeutic strategies for juvenile idiopathic arthritis (JIA) have evolved within the past ten years, and as a result, an update of the 2011 recommendations of the German management guidelines was initiated.
A systemic literature review was performed, overarching principles were proposed and pre-selected via an online survey followed by two multidisciplinary consensus conferences. Pharmacological and non-pharmacological treatments were discussed, statements were proposed and ultimately agreed upon by nominal group technique (NGT).
12 overarching therapeutic principles, as well as 9 recommendations on pharmacological and 5 on non-pharmacological treatments for JIA were agreed upon.
This report summarizes the recent update of the interdisciplinary, consensus-based German guidelines on the management of JIA. The multi- and interdisciplinary participation of all caregivers was central for this patient-focused update. With these guidelines, physicians can choose an evidence-based approach, which allows better tailored treatment in this vulnerable cohort of children and adolescents.
Keywords
Adolescent, Child, Humans, Arthritis, Juvenile/drug therapy, Consensus, Developmental Disabilities, Consensus guidelines, Juvenile idiopathic arthritis (JIA), Management of JIA, Multidisciplinary care
Pubmed
Web of science
Create date
10/10/2022 14:35
Last modification date
20/07/2023 6:57
Usage data